JERUSALEM (dpa-AFX) - (Amended: Recasting the story to correct the period, revenue)
Protalix BioTherapeutics, Inc. (PLX), a biopharmaceutical company, Monday reported a decline in earnings for the full year from last year. Annual revenues also dropped from the prior year.
However, shares of Protalix are at $2.43, up 8.92 percent in morning trade.
For the full year, net income decreased to $2.93 million from $8.31 million last year. Earnings per share also declined to $0.04 from $0.09 prior year.
Operating income came in lower at $3.92 million, compared with $10.46 million in the previous year.
Revenue for the full year declined to $53.4 million from $65.49 million last year.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
